欢迎访问心血管病防治知识,今天是

心血管病防治知识 ›› 2026, Vol. 16 ›› Issue (1): 82-89.

• 基础研究 • 上一篇    下一篇

SHH信号通路对兔急性心肌梗死血管再生的影响

杜鑫, 李昕玺, 黄涛*   

  1. 滨州医学院附属医院,山东 滨州 256600
  • 出版日期:2026-01-15 发布日期:2026-04-14
  • 通讯作者: *黄涛

Impact of sonic hedgehog signaling pathway on vascular regeneration in a rabbit model of acute myocardial infarction

DU Xin, LI Xinxi, HUANG Tao   

  1. Binzhou Medical University Hospital, Binzhou 256600, China
  • Online:2026-01-15 Published:2026-04-14

摘要: 目的 通过给予外源性SHH激动剂或抑制剂从而激活或抑制SHH信号通路,观察其在兔急性心肌梗死(AMI)模型中对血管生成的影响。方法 通过用丝线结扎新西兰大白兔左冠状动脉前降支来构建兔急性心肌梗死模型。将兔随机分为对照组(假手术组)、模型组(结扎左前降支 急性心肌梗死模型)、激动剂组(结扎左前降支,通过使用Purmorphamine激活SHH通路)、抑制剂组(结扎左前降支,通过使用Cyclopamine抑制SHH通路),术后24 h处死动物并留取静脉血液及心肌组织。采用ELISA方法检测动物模型术后24 h血清中血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF),使用免疫组化检测各组心肌组织中VEGF、bFGF蛋白的表达,实时荧光定量PCR(RT-PCP)检测各组心肌组织Hedgehog通路SHH、SMO、Gli-1 mRNA表达情况。结果 与对照组相比,急性心肌梗死模型组用ELISA方法测得的血清中VEGF、bFGF均升高(228.03±9.62pg/mL vs 306.59±12.42pg/mL,78.25±8.35pg/mL vs 141.80±5.58pg/mL),差异有统计学意义(P<0.05),与模型组相比,激动剂组VEGF、bFGF水平升高(306.59±12.42pg/mL vs 374.68±17.52pg/mL,141.80±5.58pg/mL vs 167.00±9.57pg/mL),抑制剂组VEGF、bFGF水平降低(306.59±12.42pg/mL vs 266.12±13.69pg/mL,141.80±5.58pg/mL vs 106.53±7.23pg/mL),差异有统计学意义(P<0.05);与对照组比较,模型组兔梗死心肌组织中VEGF、bFGF蛋白表达升高(0.0951±0.0080 vs 0.1732±0.0068,0.0636±0.0047 vs 0.1921±0.0063),差异有统计学意义(P<0.05),与模型组比较,激动剂组的心肌组织中VEGF、bFGF表达升高(0.1732±0.0068 vs 0.1963±0.0127,0.1921±0.0063 vs 0.2320±0.0120),抑制剂组的VEGF、bFGF表达减少(0.1732±0.0068 vs 0.1472±0.0416,0.1921±0.0063 vs 0.1645±0.0048),差异有统计学意义(P<0.05);与对照组相比,模型组SHH、SMO、Gli-1基因表达水平显著升高(1±0.058 vs 1.376±0.171,1±0.067 vs 1.202±0.877,1±0.105 vs 1.028±0.083),差异有统计学意义(P<0.05),与模型组相比,激动剂组SHH、SMO、Gli-1基因表达水平显著增高(1.376±0.171 vs 2.165±0.267,1.202±0.877 vs 1.990±0.152,1.028±0.083 vs 1.619±0.174),抑制剂组SHH、SMO、Gli-1基因表达显著下降(1.376±0.171 vs 0.911±0.15,1.202±0.877 vs 0.536±0.389,1.028±0.083 vs 0.583±0.053),差异有统计学意义(P<0.05)。结论 激活SHH信号通路,血管生成因子的表达相应增加,从而促进心肌梗死后血管生成,提示SHH信号通路激活与AMI血管再生有关。

关键词: SHH信号通路, 急性心肌梗死, 血管再生, 血管生成因子

Abstract: Objective To investigate the impact of the sonic hedgehog (SHH) signaling pathway on angiogenesis in a rabbit model of acute myocardial infarction (AMI) by administering exogenous SHH agonists or inhibitors to activate or inhibit the pathway. Methods A rabbit AMI model was established by ligating the left anterior descending coronary artery in New Zealand white rabbits using silk thread. Rabbits were randomly divided into a control group (sham operation), a model group (AMI induced by ligation of the left anterior descending coronary artery), an agonist group (ligation of the left anterior descending coronary artery and SHH pathway activation using purmorphamine), and an inhibitor group (ligation of the left anterior descending coronary artery and SHH pathway inhibition using cyclopamine). Animals were euthanized 24 h postoperatively, and venous blood and myocardial tissue samples were collected. Serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were measured using enzyme-linked immunosorbent assay at 24 h postoperatively. Immunohistochemistry was employed to detect VEGF and bFGF protein expression in myocardial tissues across groups. Real-time fluorescence quantitative PCR was used to assess the mRNA expression levels of SHH, smoothened (SMO), and glioma-associated oncogene homolog 1 (Gli-1) associated with the SHH signaling pathway within myocardial tissues. Results Compared with the control group, serum VEGF and bFGF levels in the AMI model group, as measured by enzyme-linked immunosorbent assay, were significantly elevated (228.03±9.62 pg/mL vs 306.59±12.42 pg/mL; 78.25±8.35 pg/mL vs 141.80±5.58 pg/mL; P<0.05). Relative to the model group, the agonist group exhibited increased VEGF and bFGF levels (306.59±12.42 pg/mL vs 374.68±17.52 pg/mL; 141.80±5.58 pg/mL vs 167.00±9.57 pg/mL; P<0.05), while the inhibitor group showed decreased levels (306.59±12.42 pg/mL vs 266.12±13.69 pg/mL; 141.80±5.58 pg/mL vs 106.53±7.23 pg/mL; P<0.05). Compared with the control group, VEGF and bFGF protein expression levels in infarcted myocardial tissue from the model group were significantly higher (0.0951±0.0080 vs 0.1732±0.0068; 0.0636±0.0047 vs 0.1921±0.0063; P<0.05). Relative to the model group, the agonist group showed elevated VEGF and bFGF expression (0.1732±0.0068 vs 0.1963±0.0127; 0.1921±0.0063 vs 0.2320±0.0120; P<0.05), whereas the inhibitor group showed reduced expression (0.1732±0.0068 vs 0.1472±0.0416; 0.1921±0.0063 vs 0.1645±0.0048; P<0.05). Compared with the control group, mRNA expression levels of SHH, SMO, and Gli-1 in the model group were significantly increased (1±0.058 vs 1.376±0.171; 1±0.067 vs 1.202±0.877; 1±0.105 vs 1.028±0.083; P<0.05). Relative to the model group, the agonist group exhibited significantly higher expression of SHH, SMO, and Gli-1 (1.376±0.171 vs 2.165±0.267; 1.202±0.877 vs 1.990±0.152; 1.028±0.083 vs 1.619±0.174; P<0.05), while the inhibitor group showed significantly lower expression of SHH, SMO, and Gli-1 (1.376±0.171 vs 0.911±0.15; 1.202±0.877 vs 0.536±0.389; 1.028±0.083 vs 0.583±0.053; P<0.05). Conclusion Activation of the SHH signaling pathway increases the expression of angiogenic factors, thereby promoting angiogenesis following myocardial infarction. These findings suggest that the activation of SHH signaling pathway is associated with vascular regeneration in AMI.

Key words: Sonic hedgehog signaling pathway, Acute myocardial infarction, Vascular regeneration, Angiogenic factor